Corentec Co Ltd
Corentec Co., Ltd., develops and sells orthopedic artificial joints in South Korea. Its orthopedic products include hip systems, such as Bencox ID stems, Bencox stems, Bencox modular revision stems, Bencox m stems, and Benfix long stems; and Bencox cups, Bencox bipolar cups, Bencox mirabo cups, and Bencox mirabo multi-hole cups. The company also offers Lospa and Exult knee systems; spine systems,… Read more
Corentec Co Ltd (104540) - Net Assets
Latest net assets as of September 2025: ₩85.14 Billion KRW
Based on the latest financial reports, Corentec Co Ltd (104540) has net assets worth ₩85.14 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩175.16 Billion) and total liabilities (₩90.03 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩85.14 Billion |
| % of Total Assets | 48.6% |
| Annual Growth Rate | 11.21% |
| 5-Year Change | 55.1% |
| 10-Year Change | 27.92% |
| Growth Volatility | 40.65 |
Corentec Co Ltd - Net Assets Trend (2012–2024)
This chart illustrates how Corentec Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Corentec Co Ltd (2012–2024)
The table below shows the annual net assets of Corentec Co Ltd from 2012 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩71.98 Billion | -16.42% |
| 2023-12-31 | ₩86.12 Billion | +30.99% |
| 2022-12-31 | ₩65.75 Billion | +16.09% |
| 2021-12-31 | ₩56.63 Billion | +22.04% |
| 2020-12-31 | ₩46.41 Billion | +55.00% |
| 2019-12-31 | ₩29.94 Billion | +24.30% |
| 2018-12-31 | ₩24.09 Billion | -55.66% |
| 2017-12-31 | ₩54.32 Billion | -9.74% |
| 2016-12-31 | ₩60.18 Billion | +6.96% |
| 2015-12-31 | ₩56.27 Billion | +16.49% |
| 2014-12-31 | ₩48.30 Billion | +8.59% |
| 2013-12-31 | ₩44.48 Billion | +121.13% |
| 2012-12-31 | ₩20.12 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Corentec Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4630512829000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ₩6.39 Billion | 8.88% |
| Other Components | ₩111.89 Billion | 155.45% |
| Total Equity | ₩71.98 Billion | 100.00% |
Corentec Co Ltd Competitors by Market Cap
The table below lists competitors of Corentec Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hawesko Holding AG
XETRA:HAW
|
$40.81 Million |
|
BitFuFu Inc. Class A Ordinary Shares
NASDAQ:FUFU
|
$40.83 Million |
|
Net Insight AB Series B
LSE:0H14
|
$40.83 Million |
|
Tiger Gold Corp.
V:TIGR
|
$40.84 Million |
|
CBI Co. Ltd
KQ:013720
|
$40.80 Million |
|
Ageagle Aerial Systems Inc
NYSE MKT:UAVS
|
$40.79 Million |
|
Readly International AB
ST:READ
|
$40.77 Million |
|
AEC SECURITIES
BK:BYD-R
|
$40.76 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Corentec Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 73,766,689,410 to 71,976,714,930, a change of -1,789,974,480 (-2.4%).
- Net loss of 2,584,908,750 reduced equity.
- Dividend payments of 931,489,490 reduced retained earnings.
- Share repurchases of 159,995,570 reduced equity.
- New share issuances of 159,996,000 increased equity.
- Other factors increased equity by 1,726,423,330.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-2.58 Billion | -3.59% |
| Dividends Paid | ₩931.49 Million | -1.29% |
| Share Repurchases | ₩160.00 Million | -0.22% |
| Share Issuances | ₩160.00 Million | +0.22% |
| Other Changes | ₩1.73 Billion | +2.4% |
| Total Change | ₩- | -2.43% |
Book Value vs Market Value Analysis
This analysis compares Corentec Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.04x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩6056.56 | ₩5880.00 | x |
| 2017-12-31 | ₩5466.35 | ₩5880.00 | x |
| 2018-12-31 | ₩2423.83 | ₩5880.00 | x |
| 2019-12-31 | ₩2827.80 | ₩5880.00 | x |
| 2020-12-31 | ₩3991.63 | ₩5880.00 | x |
| 2021-12-31 | ₩4787.52 | ₩5880.00 | x |
| 2022-12-31 | ₩5324.31 | ₩5880.00 | x |
| 2023-12-31 | ₩5782.28 | ₩5880.00 | x |
| 2024-12-31 | ₩5629.45 | ₩5880.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Corentec Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -3.59%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.76%
- • Asset Turnover: 0.50x
- • Equity Multiplier: 2.59x
- Recent ROE (-3.59%) is above the historical average (-8.71%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 2.40% | 2.07% | 0.60x | 1.93x | ₩-1.53 Billion |
| 2013 | 7.53% | 11.85% | 0.47x | 1.35x | ₩-1.10 Billion |
| 2014 | -3.04% | -5.52% | 0.38x | 1.46x | ₩-6.30 Billion |
| 2015 | -1.53% | -2.83% | 0.42x | 1.27x | ₩-6.49 Billion |
| 2016 | 0.77% | 1.30% | 0.37x | 1.59x | ₩-5.55 Billion |
| 2017 | -13.58% | -19.50% | 0.38x | 1.85x | ₩-12.81 Billion |
| 2018 | -123.57% | -89.10% | 0.52x | 2.67x | ₩-32.17 Billion |
| 2019 | 8.37% | 6.23% | 0.64x | 2.10x | ₩-488.30 Million |
| 2020 | 3.39% | 3.89% | 0.42x | 2.07x | ₩-3.07 Billion |
| 2021 | 1.35% | 1.71% | 0.38x | 2.10x | ₩-4.90 Billion |
| 2022 | 2.71% | 2.79% | 0.37x | 2.61x | ₩-4.79 Billion |
| 2023 | 5.50% | 4.41% | 0.49x | 2.54x | ₩-3.32 Billion |
| 2024 | -3.59% | -2.76% | 0.50x | 2.59x | ₩-9.78 Billion |
Industry Comparison
This section compares Corentec Co Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $104,831,496,000
- Average return on equity (ROE) among peers: 6.36%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Corentec Co Ltd (104540) | ₩85.14 Billion | 2.40% | 1.06x | $40.80 Million |
| Shinhung (004080) | $91.90 Billion | 13.53% | 0.59x | $10.78 Million |
| Osang Healthcare Co.,Ltd (036220) | $285.75 Billion | -3.98% | 0.03x | $37.29 Million |
| HansBiomed Corporation (042520) | $65.30 Billion | 6.15% | 0.41x | $246.58 Million |
| JVM Co. Ltd (054950) | $137.36 Billion | 7.60% | 0.46x | $117.14 Million |
| Huvitz Co. Ltd (065510) | $121.79 Billion | 7.15% | 0.82x | $42.98 Million |
| Vieworks Co. Ltd (100120) | $140.80 Billion | 14.75% | 0.11x | $100.60 Million |
| Hironic Co. Ltd (149980) | $40.72 Billion | 7.13% | 0.15x | $23.71 Million |
| Laseroptek Co., Ltd. (199550) | $-3.94 Billion | 0.00% | 0.00x | $28.16 Million |
| Hana Must SPAC 2 (208370) | $63.80 Billion | 4.94% | 0.10x | $47.77 Million |